Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer

Tracy L. Rose, Michael R. Harrison, Allison M. Deal, Sundhar Ramalingam, Young E. Whang, Blaine Brower, Mary Dunn, Chelsea K. Osterman, Hillary M. Heiling, Marc A. Bjurlin, Angela B. Smith, Matthew E. Nielsen, Hung Jui Tan, Eric Wallen, Michael E. Woods, Daniel George, Tian Zhang, Anthony Drier, William Y. Kim, Matthew I. Milowsky

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences